Department of Internal Medicine, Park-Klinik Weissensee, Berlin, Germany.
Aliment Pharmacol Ther. 2013 Jan;37(1):137-45. doi: 10.1111/apt.12124. Epub 2012 Nov 5.
Data on treatment satisfaction in European men and women with chronic constipation are limited.
To assess satisfaction with current treatment among European men and women with chronic constipation.
An internet-based survey was conducted in 2009 in 10 European countries: Austria, Germany, France, Ireland, Italy, Spain, Switzerland, the UK, Belgium and the Netherlands. Participants had self-reported chronic constipation (<3 bowel movements/week and ≥1 symptoms for ≥6 months of: pain during defecation; lumpy/hard faeces; and feeling of incomplete evacuation). Demographic data and disease history were collected. For participants using laxatives, drug name/class, satisfaction with treatment and interest in other treatments were collected.
Of the 1941 participants screened, 1355 had chronic constipation and met the inclusion criteria (chronic constipation population). The majority of the chronic constipation population who disclosed their sex (n = 811) were women (82%). Sixty-eight per cent of respondents (n = 855/1255) reported using laxatives, with the proportion of laxative users differing between subsets. Twenty-eight per cent (n = 225/793) were (very) satisfied with their treatment, whereas 44% (n = 345/793) were neutral and 28% (n = 223/793) (very) dissatisfied. There was no relationship between type of laxative and degree of (dis)satisfaction. Interest in other treatments was high with 83% (n = 686/827) of respondents 'absolutely' or 'probably' interested. Respondents dissatisfied with their treatment were more likely to be interested in other treatments.
Laxative-use is common for chronic constipation. In this large survey, 28% of participants were dissatisfied with their treatment, with the majority interested in other treatments.
欧洲慢性便秘患者的治疗满意度数据有限。
评估欧洲慢性便秘患者对当前治疗的满意度。
2009 年在 10 个欧洲国家(奥地利、德国、法国、爱尔兰、意大利、西班牙、瑞士、英国、比利时和荷兰)进行了一项基于互联网的调查。参与者自我报告患有慢性便秘(<3 次/周排便,≥6 个月存在以下 1 项或多项症状:排便时疼痛;块状/硬粪便;排便不净感)。收集了人口统计学数据和疾病史。对于使用泻药的参与者,收集了药物名称/类别、治疗满意度和对其他治疗方法的兴趣。
在筛选的 1941 名参与者中,有 1355 名患有慢性便秘并符合纳入标准(慢性便秘人群)。公开性别的慢性便秘人群中(n=811),女性占多数(82%)。68%(n=855/1255)的受访者报告使用了泻药,不同亚组的泻药使用者比例不同。28%(n=225/793)的人(非常)满意他们的治疗,而 44%(n=345/793)的人持中立态度,28%(n=223/793)的人(非常)不满意。泻药类型与(不)满意度之间没有关系。对其他治疗方法的兴趣很高,83%(n=686/827)的受访者表示“绝对”或“可能”感兴趣。对治疗不满意的受访者更有可能对其他治疗方法感兴趣。
慢性便秘常使用泻药治疗。在这项大型调查中,28%的参与者对他们的治疗不满意,大多数人对其他治疗方法感兴趣。